Literature DB >> 9218744

Cutaneous malignant melanoma in Northern Ireland.

P J Pedlow1, M Y Walsh, C C Patterson, R J Atkinson, W S Lowry.   

Abstract

The results of two 5-year studies, for 1974-78 and 1984-88, of cutaneous malignant melanoma (CMM) in Northern Ireland show changes in the presentation of the disease. Although there is some evidence of earlier diagnosis, the rise in incidence has produced an overall increase in the number of cases with advanced disease.

Entities:  

Mesh：

Year:  1997        PMID： 9218744      PMCID： PMC2223795          DOI： 10.1038/bjc.1997.347

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  6 in total

1.  Malignant melanoma in Denmark. Occurrence and risk factors.

Authors:  A Osterlind
Journal:  Acta Oncol       Date:  1990       Impact factor: 4.089

2.  Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987.

Authors:  R P Gallagher; B Ma; D I McLean; C P Yang; V Ho; J A Carruthers; L M Warshawski
Journal:  J Am Acad Dermatol       Date:  1990-09       Impact factor: 11.527

3.  Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group.

Authors:  R MacKie; J A Hunter; T C Aitchison; D Hole; K Mclaren; R Rankin; K Blessing; A T Evans; A W Hutcheon; D H Jones
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

4.  Increasing incidence of cutaneous melanoma in Queensland, Australia.

Authors:  R MacLennan; A C Green; G R McLeod; N G Martin
Journal:  J Natl Cancer Inst       Date:  1992-09-16       Impact factor: 13.506

5.  Poor prognosis for malignant melanoma in Northern Ireland: a multivariate analysis.

Authors:  L G Gordon; W S Lowry; P J Pedlow; C C Patterson
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

6.  Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden.

Authors:  M Thörn; F Pontén; R Bergström; P Sparén; H O Adami
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.